BioCentury
ARTICLE | Finance

TVM's Canadian flavor

Teralys Capital, Eli Lilly go for new TVM biotech fund in Canada

June 4, 2012 7:00 AM UTC

Canadian fund-of-funds investor Teralys Capital made its second life sciences commitment this year, putting $65 million into an initial $150 million close for TVM Life Science Ventures VII.

Teralys has $700 million under management and invests in venture funds focused on life sciences, IT and cleantech. About one third of its venture allocation goes to life sciences, Teralys' Eric Legault told BioCentury...